Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study

No abstract is available for this paper.

• Publication year

  2011

• Venue

  European Journal of Clinical Pharmacology

• Publication date

  2011-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00228-010-0958-3PMID 21152908
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Statins in prevention of repeat revascularization after percutaneous coronary intervention--a meta-analysis of randomized clinical trials.

  2010cited by this paper
• Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.

  2010cited by this paper
• Drug therapies for the primary prevention of cardiovascular events: trials and errors: 2009 Ancel Keys Memorial Lecture.

  2010influential reference
• Effect of statin adherence on cerebrovascular disease in primary prevention.

  2009cited by this paper
• Benefit of statins in daily practice? A six-year retrospective observational study.

  2009cited by this paper
• The Healthy Adherer Meet

  2009cited by this paper
• Trial evidence for statin-based primary prevention remains dubious.

  2009cited by this paper
• Impact of better adherence to statin agents in the primary prevention of coronary artery disease

  2009cited by this paper
• The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

  2009cited by this paper
• The healthy adherer effect.

  2009cited by this paper
• Continuation of statin treatment and all-cause mortality: a population-based cohort study.

  2009cited by this paper
• Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting.

  2009cited by this paper
• Lipid lowering for primary prevention.

  2009cited by this paper
• Should statins be prescribed for primary prevention of cardiovascular disease in patients with chronic kidney disease?

  2009cited by this paper
• Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.

  2008cited by this paper
• Adherence to statin therapy and patients’ cardiovascular risk: a pharmacoepidemiological study in Italy

  2008cited by this paper
• Immeasurable time bias in observational studies of drug effects on mortality.

  2008cited by this paper
• Expanding the orbit of primary prevention--moving beyond JUPITER.

  2008cited by this paper
• Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis.

  2008cited by this paper
• Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction.

  2007cited by this paper
• Are lipid-lowering guidelines evidence-based?

  2007cited by this paper
• Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data.

  1999cited by this paper

• Adherence to statins and development of atherosclerosis-related events. A systematic review and meta-analysis.

  2025cites this paper
• Exploring the Cardiovascular Benefits of Extra Virgin Olive Oil: Insights into Mechanisms and Therapeutic Potential

  2025cites this paper
• Introduction to Data Linkage

  2024cites this paper
• Measurement Properties of Patient-Reported Outcome Measures for Medication Adherence in Cardiovascular Disease: A COSMIN Systematic Review

  2022cites this paper
• Statin adherence and LDL-C reduction in a pediatric population

  2020cites this paper
• Приверженность фармакотерапии сердечно-сосудистых заболеваний: современное состояние вопроса

  2020cites this paper
• Cost effectiveness of interventions to improve adherence to statin therapy in ASCVD patients in the United States

  2019cites this paper
• Cost effectiveness of interventions to improve adherence to statin therapy in ASCVD patients in the United States

  2019cites this paper
• PPA_A_213258 1375..1389

  2019cites this paper
• Psychometric properties of self-reported medication adherence tools in cardiovascular disease: a systematic review protocol.

  2019cites this paper
• Identifying Factors Which Influence Medication Adherence in a Cardiac Rehabilitation Population

  2018cites this paper
• Systematic Review of the Effect of Adherence to Statin Treatment on Critical Cardiovascular Events and Mortality in Primary Prevention

  2018cites this paper
• Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system?

  2018cites this paper
• Cardiovascular medication adherence among patients with cardiac disease: a systematic review.

  2016cites this paper
• Statin treatment in type 2 diabetes patients

  2016cites this paper
• Statin Adherence After Ischemic Stroke or Transient Ischemic Attack Is Associated With Clinical Outcome.

  2016cites this paper
• Perfil epidemiológico y prevención secundaria en la primera visita del paciente claudicante a la consulta de angiología y cirugía vascular: estudio ESCUTEPAC

  2016cites this paper
• Using linked administrative data for monitoring and evaluating the Family Nurse Partnership in England: A scoping report

  2016cites this paper
• Patient-Centered Interventions to Improve Adherence to Statins: A Narrative Synthesis of Systematically Identified Studies

  2016cites this paper
• From statin efficacy to everyday effectiveness: Studying the gap in between.

  2015cites this paper
• Does a cardiovascular event change adherence to statin treatment in patients with type 2 diabetes? A matched cohort design

  2015cites this paper
• The Burden of Non-Adherence to Cardiovascular Medications Among the Aging Population in Australia: A Meta-Analysis

  2015cites this paper
• Original article Does a cardiovascular event change adherence to statin treatment in patients with type 2 diabetes? A matched cohort design

  2015cites this paper
• Associations Between Statin Adherence Level, Health Care Costs, and Utilization

  2014cites this paper
• Factors associated with 2-year persistence in fully non reimbursed lipid-lowering treatments.

  2014cites this paper
• Correction: Pattern of Statin Use in Southern Italian Primary Care: Can Prescription Databases Be Used for Monitoring Long-Term Adherence to the Treatment?

  2014cites this paper
• Statin treatment non-adherence and discontinuation: clinical implications and potential solutions.

  2014cites this paper
• Pattern of Statin Use in Southern Italian Primary Care: Can Prescription Databases Be Used for Monitoring Long-Term Adherence to the Treatment?

  2014cites this paper
• Trend in SSRI-SNRI antidepressants prescription over a 6-year period and predictors of poor adherence

  2013cites this paper
• An education-behavioural intervention improves adherence to statins

  2013cites this paper
• Persistence with statin therapy in Hungary

  2013cites this paper
• Impact of compliance with antihypertensive and lipid-lowering treatment on cardiovascular risk Benefits of fixed-dose combinations

  2013cites this paper
• Differences in interaction and subgroup-specific effects were observed between randomized and nonrandomized studies in three empirical examples.

  2013cites this paper
• Burden of psychiatric disorders in the pediatric population.

  2013cites this paper
• Prevalence and reasons for non-adherence to hyperlipidemia treatment

  2013cites this paper
• The public cost of 3 statins for primary prevention of cardiovascular events in 7 Middle East countries: not all of them can afford it.

  2012cites this paper